1. International Conference on Harmonization Guideline for industry, S2A: Specific aspects of regulatory genotoxicity tests for pharmaceuticals, 1996 http://www.fda.gov/cder/guidance/ichs2a.pdf, Accessed October 9, 2008.
2. International Conference on Harmonization Guidance for industry, S2B Genotoxicity: a standard battery for genotoxicity testing of pharmaceuticals, 1997 http://www.fda.gov/CDER/guidance/1856fnl.pdf, Accessed October 9, 2008.
3. Comparative overview of current international strategies and guidelines for genetic toxicology testing for regulatory purposes;Cimino;Environ. Mol. Mutagen.,2006
4. Use of genetic toxicology information for risk assessment;Dearfield;Environ. Mol. Mutagen.,2005
5. US EPA Guidelines for carcinogen risk assessment and supplemental guidance for assessing susceptibility from early-life exposure to carcinogens, Federal Register 70 (2005) 17765–17817.